Adverum Biotechnologies Inc (NAS:ADVM) Stock News, Headlines & Updates
Adverum Biotechnologies Inc Stock News from GuruFocus
- 1
Jun 26, 2025
Adverum Biotechnologies (ADVM) Price Target Reduced by Mizuho | ADVM Stock News
GuruFocus News • 10:04am
Adverum Biotechnologies (ADVM) Price Target Reduced by Mizuho | ADVM Stock News
GuruFocus News • 8:15am
Jun 05, 2025
Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Marketwired • 4:00pm
Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ADVM Stock News
GuruFocus News • 3:19pm
May 15, 2025
Adverum Biotechnologies (ADVM) Sees Price Target Adjustment by RBC Capital | ADVM Stock News
GuruFocus News • 11:31am
Adverum Biotechnologies (ADVM) Receives Continued Buy Rating from Chardan Capital | ADVM Stock News
GuruFocus News • 11:02am
Adverum Biotechnologies (ADVM) Price Target Reduced by RBC Capital | ADVM Stock News
GuruFocus News • 8:09am
Adverum Biotechnologies (ADVM) Rating Reiterated at 'Buy' by HC Wainwright | ADVM Stock News
GuruFocus News • 6:32am
May 14, 2025
Adverum (ADVM) Projects Funding Through Late 2025 | ADVM Stock News
GuruFocus News • 4:05pm
Adverum Biotechnologies Reports First Quarter 2025 Financial Results and Provides Pipeline Highlights
Marketwired • 4:00pm
Adverum Biotechnologies Reports Q1 2025 Net Loss of $2.25 Per Share, Missing EPS Estimate; Revenue Remains at $0
GuruFocus News • 3:39pm
May 09, 2025
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM
Marketwired • 7:00am
May 06, 2025
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM
PRNewswire • 4:00pm
May 05, 2025
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM
Marketwired • 2:00pm
May 02, 2025
Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Marketwired • 4:00pm
Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ADVM Stock News
GuruFocus News • 3:18pm
Apr 29, 2025
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM
Marketwired • 11:00am
Apr 28, 2025
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM
PRNewswire • 6:00pm
Apr 25, 2025
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM
Marketwired • 1:00pm
Apr 22, 2025
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM
PRNewswire • 3:00pm
Apr 21, 2025
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM
Marketwired • 2:00pm
Apr 17, 2025
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM
Marketwired • 12:00pm
Apr 15, 2025
ADVM Investors Have Opportunity to Join Adverum Biotechnologies, Inc. Fraud Investigation with the Schall Law Firm
PRNewswire • 9:00am
Adverum (ADVM) Financial Position: Cash Reserves Decline in Q4 2024 | ADVM Stock News
GuruFocus News • 7:15am
Adverum Biotechnologies Inc Reports Q4 2024 EPS of -$1.96, Missing Estimates; No Revenue Reported
GuruFocus News • 7:13am
Adverum Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Pipeline Highlights and Updates to Anticipated Milestones | ADVM Stock News
GuruFocus News • 7:01am
Ixo-vec Gene Therapy Advances with Pivotal Trial Launch | ADVM Stock News
GuruFocus News • 7:01am
Adverum Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Pipeline Highlights and Updates to Anticipated Milestones
Marketwired • 7:00am
Apr 14, 2025
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM
PRNewswire • 6:00pm
ADVM Investors Have Opportunity to Join Adverum Biotechnologies, Inc. Fraud Investigation with the Schall Law Firm
Business Wire • 8:00pm
Apr 12, 2025
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM
Marketwired • 9:00am
Apr 08, 2025
- 1
Show
Entries
Headlines
Total 0- 1
No recent news